A (b)(6) year-old female patient used 1 dose of hyalgan (hyaluronate sodium) via intra-articular route, for osteoarthritis, on (b)(6) 2021 and diprostene (betamethasone dipropionate; betamethasone sodium phosphate) unknown pharmaceutical form, at unknown dose, for unknown indication.On the same date, the patient experienced malaise and respiratory arrest.At the time of the reporting, the outcome was resolved.Reaction as described by the primary source: after the injection of a corticosteroid (diprostene) + hyalgan, the patient presented with malaise followed by respiratory arrest.Concomitant medication: algicare (anti-inflammatory food supplement); algesic plus (paracetamol+codeine); aléogine (a harpagophytum-based gel) medical history: asthmatic patient.No further information is available.
|